Addiction

Reducing stigma towards people living with HIV and people who inject drugs

Broady, T. R., Brener, L., Horwitz, R., Cama, E., & Treloar, C. (2023). Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers. Drug and Alcohol Dependence, 109953. https://doi.org/10.1016/j.drugalcdep.2023.109953

Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of initiatives to reduce this stigma.

Recovery Capital: Assets, Not Abstinence

Online,
Description

What do individuals need to recover from addiction? In this training, we will first describe recovery capital as a predictor of long-term addiction recovery. Second, we will discuss how we characterize substance use disorder (SUD) as a chronic condition and lean into the complexity of the heterogeneity of SUD and recovery as a process of change.

Embracing Recovery-Oriented Harm Reduction in Medication Assisted Treatment

Online,
Description

Medication-assisted treatment (MAT) is widely accepted as the most effective form of treatment for individuals with opioid use disorder. MAT options have offered a pathway to recovery for many individuals who have found sustained, long-term recovery with the support of these medications and services. Despite this, MAT is often categorized as a form of harm reduction.

V Congreso Internacional sobre prevención, tratamiento y control del consumo de cannabis

Ourense, Spain,

PRESENTACIÓN

Este año celebramos el IV Congreso Internacional sobre prevención, tratamiento y control del consumo de cannabis es una iniciativa científica que pretende aglutinar a profesionales sanitarios, del ámbito judicial y de la educación, estudiantes de las ramas socio-sanitaria y todas aquellas personas interesadas por dar una respuesta a los problemas derivados del consumo de cannabis, fenómeno que ha sufrido

Treatment for drug and alcohol misuse should involve families and communities

Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant role in an individuals journey through recovery. This article, published in the Conversation, explores the potential role of families in treatment in Australia. The authors go on to suggest 3 ways of expanding access and creating a family-focused model

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two formulations, a weekly injection that can be used in patients who have started treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine, and a monthly version for patients

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023 Jun;22(2):203-229. doi: 10.1002/wps.21073. PMID: 37159360; PMCID: PMC10168177.
Publication Date

Abstract

Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and self-awareness underlie the intense drive to consume substances and the inability to control this urge in a person who suffers from addiction (moderate or severe SUD).